Researchers developed a new antifungal gel containing luliconazole loaded into tiny lipid nanoparticles to treat stubborn fungal skin infections caused by Trichophyton indotineae that resist standard terbinafine treatment. Testing in guinea pigs showed this new nanoformulation penetrated skin better and cleared infections faster (21 days) compared to regular luliconazole gel (28 days) and terbinafine-treated animals. The nanoparticle delivery system improved the drug’s ability to reach infected skin layers and showed no harmful side effects, offering promise for treating resistant fungal infections in patients.